Wakefield, Massachusetts – April 7, 2014 – The tranSMART Foundation, a non-profit organization providing a global, open- source knowledge management platform for scientists to share pre-competitive translational research data, today an- nounced that Rudy Potenzone, Ph.D. has been appointed to VP of Marketing. As a seasoned veteran in the life sciences industry, Dr. Potenzone is responsible for elevating the awareness of the tranSMART Foundation’s brand throughout the biotech and pharmaceutical markets.

“Last year we built a strong base for the Foundation with the launch of version 1.1 of the tranSMART open source platform and the growth of our core community,” said Keith Elliston, Ph.D., CEO of the Foundation. “Now, we are in the position to market our platform to the larger community and with Rudy’s marketing expertise, we believe we can reach our goal to increase awareness in the marketplace of the tranSMART platform and its value.”

“The mission of the tranSMART Foundation to enable collaborative translational research through the mobilization of its open source community is a key component for the evolution of translational medicine,” said Dr. Potenzone. “I’m excited to join the tranSMART Foundation team and to lead the marketing efforts that will stimulate growth of the community and increase the use of the tranSMART platform in scientific research.

Dr. Potenzone has spent more than 30 years designing and delivering novel and integrated solutions across the life science, biological and chemical industries. His background includes recent positions at PerkinElmer as the VP of Product Strategy (Informatics); at Microsoft as worldwide pharma industry technology strategist; and president of Lion Biosciences US. Previ- ously, as senior vice president of Research and Development at MDL, he initiated the development of Isentris and Discovery Gate. Prior to that, he was director of New Product Development and Research for Chemical Abstracts, developing SciFinder and SciFinder Scholar.

Dr. Potenzone holds a Ph.D. and an M.S. in macromolecular science from Case Western Reserve University and a B.S. in bio-physics from the University of Pittsburgh.